BioMarin Announces Proposed Private Offering of $500 Million of Senior Subordinated Convertible Notes

SAN RAFAEL, CA (STL.News) BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that it intends to offer,…

Autodesk to Present at Upcoming Investor Conferences

(STL.News) – Autodesk, Inc. (NASDAQ: ADSK) today announced its executives will be — Credit Suisse Tech…

BioMarin to Participate in Jefferies London Healthcare Conference on November 21, 2019

(STL.News) – BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive…

Autodesk Unveils Robust New Features for BIM 360Autodesk Unveils Robust New Features for BIM 360

San Rafael, Calif., (STL.News) – Autodesk, Inc. (NASDAQ: ADSK) today announced enhancements to BIM 360, including…

BioMarin to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, October 23 at 4:30pm ET

San Rafael, Calif., (STL.News) –  BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman…

BioMarin Promotes Lon Cardon, Ph.D. to Chief Scientific Strategy Officer

San Rafael, (STL.News) – BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced the promotion of Lon Cardon, Ph.D.…

BioMarin to Participate in Jefferies Gene Therapy/Editing Summit on October 8, 2019 in New York

San Rafael, Calif., (STL.News) – BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Robert Baffi, Ph.D.,…